kr33.52
3.51% yesterday
Stockholm, Dec 05, 05:29 pm CET
ISIN
SE0014428512
Symbol
SUS

Surgical Science Sweden AB Stock price

kr33.52
-47.48 58.62% 1M
-118.28 77.92% 6M
-122.38 78.50% YTD
-113.28 77.17% 1Y
-126.68 79.08% 3Y
-52.98 61.25% 5Y
-25.23 42.94% 10Y
-25.23 42.94% 20Y
Stockholm, Closing price Fri, Dec 05 2025
-1.22 3.51%
ISIN
SE0014428512
Symbol
SUS

Key metrics

Basic
Market capitalization
kr1.7b
Enterprise Value
kr1.1b
Net debt
positive
Cash
kr597.4m
Shares outstanding
51.0m
Valuation (TTM | estimate)
P/E
25.4 | 13.8
P/S
1.7 | 1.6
EV/Sales
1.1 | 1.0
EV/FCF
63.5
P/B
0.4
Financial Health
Equity Ratio
88.1%
Return on Equity
2.7%
ROCE
1.5%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
kr975.0m | kr1.1b
EBITDA
kr141.4m | kr208.4m
EBIT
kr67.9m | kr138.4m
Net Income
kr69.8m | kr128.5m
Free Cash Flow
kr17.2m
Growth (TTM | estimate)
Revenue
13.4% | 21.3%
EBITDA
-10.1% | 2.7%
EBIT
-52.4% | -4.1%
Net Income
-63.9% | -2.4%
Free Cash Flow
-76.4%
Margin (TTM | estimate)
Gross
66.6%
EBITDA
14.5% | 19.4%
EBIT
7.0%
Net
7.2% | 12.0%
Free Cash Flow
1.8%
More
EPS
kr1.4
FCF per Share
kr0.3
Short interest
-
Employees
274
Rev per Employee
kr3.2m
Show more

Is Surgical Science Sweden AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

Surgical Science Sweden AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Surgical Science Sweden AB forecast:

5x Buy
63%
3x Hold
38%

Analyst Opinions

8 Analysts have issued a Surgical Science Sweden AB forecast:

Buy
63%
Hold
38%

Financial data from Surgical Science Sweden AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
975 975
13% 13%
100%
- Direct Costs 326 326
21% 21%
33%
650 650
10% 10%
67%
- Selling and Administrative Expenses 255 255
9% 9%
26%
- Research and Development Expense 186 186
0% 0%
19%
141 141
10% 10%
14%
- Depreciation and Amortization 73 73
410% 410%
8%
EBIT (Operating Income) EBIT 68 68
52% 52%
7%
Net Profit 70 70
64% 64%
7%

In millions SEK.

Don't miss a Thing! We will send you all news about Surgical Science Sweden AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Surgical Science Sweden AB engages in the development of simulators for laparoscopic medical training. Its products include LapSim, offers a procedural simulation for cholecystectomy, appendectomy, advanced suturing and anastomosis, gynecology, hysterectomy, bariatrics, and nephrectomy; EndoSim, for endoscopy simulation; and TeamSim, for realistic training of collaboration within a surgery team. The company was founded by Anders Hyltander, David Löfstrand, and Anders Larsson on July 24, 1997 and is headquartered in Gothenburg, Sweden.

Head office Sweden
CEO Mr. Englund
Employees 274
Founded 1997
Website surgicalscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today